All In MedTech

FDA Clearance Tracker · P210011-S004

xT CDx

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 28, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P210011-S004
Device name
xT CDx
Applicant location
Chicago, IL
Received
Jun 30, 2025
Decided
May 28, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P210011

Device type

Device class
Class III

Every decision under product code PQP

FDA's approval statement

As written in FDA's record.

Addition of an alternative method of germline subtraction and implementing an updated MSI caller in the bioinformatics pipeline.

Source documents

Other decisions for Tempus AI, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.